Form 8-K - Current report:
SEC Accession No. 0001384101-25-000010
Filing Date
2025-02-24
Accepted
2025-02-24 16:11:03
Documents
15
Period of Report
2025-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20250224.htm   iXBRL 8-K 29374
2 EX-99.1 vcyt-02x24x20258xkearnings.htm EX-99.1 351525
6 GRAPHIC vcytlogoa.gif GRAPHIC 5822
  Complete submission text file 0001384101-25-000010.txt   542867

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20250224.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20250224_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20250224_pre.xml EX-101.PRE 13060
17 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20250224_htm.xml XML 2823
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 25657098
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)